4.7 Article

Synthesis and biological evaluation of 3-substituted 2-oxindole derivatives as new glycogen synthase kinase 3β inhibitors

Journal

BIOORGANIC & MEDICINAL CHEMISTRY
Volume 27, Issue 9, Pages 1804-1817

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2019.03.028

Keywords

Oxindole derivatives; Indolin-2-one; GSK3 beta; Glycogen synthase kinase 3; Antidiabetic; 3-Substituted indolinone; Anticancer

Funding

  1. Russian Foundation for Basic Research (RFBR), Russia [17-03-01320]
  2. Council on grants of the President of the Russian Federation [SP-595.2018.4]

Ask authors/readers for more resources

Glycogen synthase kinase 3 beta (GSK-3 beta) is a widely investigated molecular target for numerous diseases including Alzheimer's disease, cancer, and diabetes mellitus. Inhibition of GSK-3 beta activity has become an attractive approach for treatment of diabetes and cancer. We report the discovery of novel GSK-3 beta inhibitors of 3-arylidene-2-oxindole scaffold with promising activity. The most potent compound 3a inhibits GSK-3 beta with IC(50 )4.19 nM. In a cell-based assay 3a shows no significant leucocyte toxicity at 10 mu M and is moderately cytotoxic against A549 cells. Compound 3a demonstrated high antidiabetic efficacy in obese streptozotocin-treated rats improving glucose tolerance at a dose of 50 mg/kg body weight thus representing an interesting lead for further optimization.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Chemistry, Multidisciplinary

Sodium dithionite in the regioselective reduction of the ortho-positioned nitro group in 1-R-2,4-dinitrobenzenes

Michael D. Tsymliakov, Anita I. Maksutova, Elena N. Bezsonova, Daria Zakharova, Yuri K. Grishin, Victor A. Tafeenko, Sergey E. Sosonyuk, Natalia A. Lozinskaya

Summary: 1-R-2,4-Dinitrobenzenes can be selectively reduced using sodium dithionite at near-neutral pH to produce the product with an amino group ortho to the substituent R. While the yields of the products varied from moderate to good, this procedure avoids the use of transition metals.

MENDELEEV COMMUNICATIONS (2023)

Article Biochemistry & Molecular Biology

3-Arylidene-2-oxindoles as Potent NRH:Quinone Oxidoreductase 2 Inhibitors

Natalia A. Lozinskaya, Elena N. Bezsonova, Meriam Dubar, Daria D. Melekhina, Daniil R. Bazanov, Alexander S. Bunev, Olga B. Grigor'eva, Vladlen G. Klochkov, Elena V. Sokolova, Denis A. Babkov, Alexander A. Spasov, Sergey E. Sosonyuk

Summary: The enzyme NRH:quinone oxidoreductase 2 (NQO2) is involved in the progression of various diseases and is known to be increased in some cancer cell lines. This study examined the activity of 3-arylidene-2-oxindoles, commonly used in the design of new anticancer drugs, as NRH:quinone oxidoreductase inhibitors. The most active compounds showed significant inhibition of NQO2, but there was no correlation between their inhibition activity and cytotoxic effect on cancer cells.

MOLECULES (2023)

Article Biochemistry & Molecular Biology

Amino Derivatives of Diaryl Pyrimidines and Azolopyrimidines as Protective Agents against LPS-Induced Acute Lung Injury

Alexander Spasov, Irina Ovchinnikova, Olga Fedorova, Yulia Titova, Denis Babkov, Vadim Kosolapov, Alexander Borisov, Elena Sokolova, Vladlen Klochkov, Maria Skripka, Yulia Velikorodnaya, Alexey Smirnov, Gennady Rusinov, Valery Charushin

Summary: The problem of lung damage caused by excessive inflammation and cytokine release during infections is still a concern. This study focuses on the design and synthesis of amino derivatives of specific pyrimidines as potential drugs inhibiting IL-6 and NO. Testing on murine macrophages showed that seven compounds inhibited the synthesis of nitric oxide and interleukin 6 at a concentration of 100 μM. The most active compounds demonstrated minimal impact on innate immunity, unlike the reference drug dexamethasone, and showed promising protective activity in an animal model of acute lung injury.

MOLECULES (2023)

Article Chemistry, Medicinal

3-Arylidene-2-oxindoles as GSK3β inhibitors and anti-thrombotic agents

Denis Babkov, Elena Bezsonova, Viktor Sirotenko, Elias Othman, Vladlen Klochkov, Sergey Sosonyuk, Natalia Lozinskaya, Alexander Spasov

Summary: Development of novel agents that prevent thrombotic events is urgently needed, and GSK3 beta inhibitors showed promising results. The most active compound, 5a, demonstrated significantly higher antiplatelet and antithrombotic activities compared to acetylsalicylic acid. These findings support the potential role of GSK3 beta inhibitors in the development of new antithrombotic agents.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2023)

Article Chemistry, Medicinal

The rational design of novel 5-amino-2-oxindole derivatives with antiglaucomic activity

Roman O. Eremeev, Olga V. Beznos, Alexander M. Efremov, Natalia B. Chesnokova, Natalia A. Lozinskaya

Summary: Compounds with a 2-oxindole scaffold are important in organic synthesis and the synthesis of bioactive organic compounds. Developing new methods to modify this scaffold is an interesting and urgent task. In this study, a rational approach to the synthesis of 5-amino-substituted derivatives of 2-oxindole has been created, characterized by high total yield and few steps. The one-stage modification of the obtained 5-amino-2-oxindoles leads to compounds with promising antiglaucomic activity, with the most active compound 7a reducing intraocular pressure by 24% in normotensive rabbits (18% for the reference drug timolol).

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2023)

Article Pharmacology & Pharmacy

New Organometallic Ru(II) Compounds with Lonidamine Motif as Antitumor Agents

Ilya A. Shutkov, Yulia N. Okulova, Dmitrii M. Mazur, Nikolai A. Melnichuk, Denis A. Babkov, Elena V. Sokolova, Alexander A. Spasov, Elena R. Milaeva, Alexey A. Nazarov

Summary: The combination of organic and metal-based fragments with antitumor activity is a modern approach to discover new drugs. This study introduces biologically active ligands based on lonidamine into antitumor organometallic ruthenium scaffold. The stability in ligand exchange reactions does not affect cytotoxicity, while the introduction of a second lonidamine fragment doubles the cytotoxicity. The ability to induce apoptosis and caspase activation in tumor cells was also studied.

PHARMACEUTICS (2023)

Review Pharmacology & Pharmacy

Models of neuroinflammation for the assessment of kappa-opioid receptor ligands

K. Yu. Kalitin, A. A. Spasov, O. Yu. Mukha

Summary: The study provides a summary of the current strategies used to evaluate the neuroinflammatory effects of kappa-opioid ligands in laboratory animals with induced neuroinflammation. Various experimental models of neuroinflammation were evaluated, and the strengths and limitations of each model were assessed to identify the most appropriate approach for investigating the relationship between neuroinflammation and kappa-opioid receptors.

PHARMACY & PHARMACOLOGY-FARMATSIYA I FARMAKOLOGIYA (2023)

Article Biochemistry & Molecular Biology

Synthesis and antiglycation activity of 3-phenacyl substituted thiazolium salts, new analogs of Alagebrium

Alexander Ozerov, Darya Merezhkina, Fedor I. Zubkov, Roman Litvinov, Umida Ibragimova, Nikita Valuisky, Alexander Borisov, Alexander Spasov

Summary: This study synthesized and investigated a series of 3-phenacyl substituted thiazolium salts, analogs of Alagebrium, as glycation reaction inhibitors. The leader compound showed high effectiveness against the three examined mechanisms of glycation reaction and was able to suppress the formation of AGEs.

CHEMICAL BIOLOGY & DRUG DESIGN (2023)

Article Biochemistry & Molecular Biology

Novel Substituted Azoloazines with Anticoagulant Activity

Alexander A. Spasov, Olga V. Fedorova, Nikolay A. Rasputin, Irina G. Ovchinnikova, Rashida I. Ishmetova, Nina K. Ignatenko, Evgeny B. Gorbunov, Gusein A. O. Sadykhov, Aida F. Kucheryavenko, Kseniia A. Gaidukova, Victor S. Sirotenko, Gennady L. Rusinov, Egor V. Verbitskiy, Valery N. Charushin

Summary: The development of new anticoagulants is urgently needed for the treatment of COVID-19 patients, and drugs that combine anticoagulant properties with antiviral or antidiabetic activity could be particularly helpful, especially for patients with concomitant arterial hypertension or diabetes.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Chemistry, Multidisciplinary

a-Glucosidase Inhibitors Based on Oleanolic Acid for the Treatment of Immunometabolic Disorders

Anastasiya V. Petrova, Denis A. Babkov, Elmira F. Khusnutdinova, Irina P. Baikova, Oxana B. Kazakova, Elena V. Sokolova, Alexander A. Spasov

Summary: A series of new oleanane-type triterpenic derivatives were synthesized from oleanolic acid through various reactions and were evaluated for their potential as treatments for immunometabolic disorders. The compounds showed strong inhibition against a-glucosidase enzyme but had no activity against PTP1B. One particular compound, N-methylpiperazine methylated 2,3-indolo-oleanolic propargyl amide 15, also demonstrated inhibitory effects on NO synthesis and oxidative bursts, making it a promising prototype drug for immunometabolic defects in type 2 diabetes.

APPLIED SCIENCES-BASEL (2023)

No Data Available